Can a Vermont resident get peptides by telehealth?
18 V.S.A. section 9361 lets a Vermont-licensed health care provider prescribe, dispense, or administer drugs after an appropriate examination performed in person, through telemedicine, or by instrumentation and diagnostic equipment that transmits images and medical records electronically, and it holds electronic prescribing to the same standards as a traditional setting. The section also covers services delivered by store-and-forward means, requires the originating site to obtain informed consent for store-and-forward services, and preserves the patient's right to a later real-time or in-person visit. Definitions follow 8 V.S.A. section 4098a (telemedicine and store-and-forward). The prescriber must be licensed in Vermont or practice under Vermont's telehealth licensure or registration pathway administered by the Office of Professional Regulation. Because the statute expressly recognizes examination through transmitted images and records and store-and-forward delivery, this record marks asynchronous prescribing as allowed, subject to the standard of care. GLP-1 medicines and the peptides in this database are not controlled substances. [4] [5] [6]
How does the Vermont pharmacy board treat compounding?
| Board | Vermont Board of Pharmacy (Office of Professional Regulation, Vermont Secretary of State) |
|---|---|
| Eligible substances | Follows the federal 503A framework |
The Vermont Board of Pharmacy, administered by the Office of Professional Regulation, licenses pharmacists and drug outlets under 26 V.S.A. chapter 36. Section 2061 requires every drug outlet to register and hold a license in one or more classifications, including retail, compounding, outsourcing, and home infusion, and the Board sets the criteria for each by rule. The Board's administrative rules effective February 1, 2026 settle both points. Rule 10-9 requires a drug outlet physically located outside Vermont but doing business in Vermont to register for the applicable license type; rule 7-4(b) requires a nonresident outlet to submit an inspection report assessing compliance with applicable law and USP standards, done by its home-state board, the national pharmacy boards association, FDA, or another recognized third party within 2 years before application for a compounding or home infusion pharmacy; and rule 6-2 requires a qualifying inspection at each renewal. Rule 10-4 requires a pharmacy that compounds to register as a compounding pharmacy in addition to its retail license and to comply with 21 U.S.C. 353a, USP chapter 795 for non-sterile compounding, USP chapter 797 for sterile compounding, and USP chapter 800 for hazardous drugs, and to compound only on a patient-specific order or in limited quantities based on regularly observed prescribing patterns. Vermont has not adopted its own list of compoundable bulk substances, so a peptide's eligibility follows the federal 503A test (approved drug component, USP or NF monograph, or FDA 503A bulks list). [1] [2] [3] [7] [8] [9]
Can you get compounded GLP-1s in Vermont?
A pharmacy compounding a GLP-1 for a Vermont patient must hold the appropriate Vermont drug outlet license, including a nonresident license if it ships from out of state. [1] [8] [12]
Prices by channel: semaglutide cost, tirzepatide cost.
Approvals, shortage history, and prices for every GLP-1 we track are on the GLP-1 hub.
What is the legal access path in Vermont?
Verified access options
Prescriber licensed in Vermont, in person or by telehealth
Telehealth prescribing of non-controlled peptides is permitted in Vermont. Asynchronous (questionnaire or messaging) prescribing is permitted when it meets the standard of care.
Check the dispensing pharmacy against the board's license lookup before paying, including out-of-state mail-order pharmacies.
Branded GLP-1 through a retail or manufacturer pharmacy
FDA approved semaglutide and tirzepatide are available by prescription. Compounded GLP-1 limited; see the GLP-1 section for why.
Access paths are verified against public regulatory records and prescriber licensing. We never list unlicensed vendors.
Find a provider in Vermont
Is it legal to buy research peptides in Vermont?
Under 26 V.S.A. chapter 36, drugs may be dispensed to Vermont patients only by licensed pharmacists working in licensed drug outlets, so a seller shipping "research use only" injectable peptides to Vermont consumers is not a licensed outlet. [7] [13]
Peptide-specific notes for Vermont
| Peptide | Note |
|---|---|
| Semaglutide | Available branded by prescription, including from a Vermont-authorized prescriber after a telemedicine or store-and-forward examination under 18 V.S.A. 9361. Compounded semaglutide is limited to the federal patient specific exception since the 503A grace period ended April 22, 2025. [5] [12] |
Frequently asked questions
Can I get a GLP-1 prescription in Vermont through telemedicine?
Yes. 18 V.S.A. section 9361 allows a Vermont-licensed provider to prescribe after an appropriate examination done in person, through telemedicine, or with equipment that transmits images and medical records electronically, held to the same standard as an office visit. [5]
Does Vermont allow store-and-forward telehealth?
Yes. Section 9361 covers services delivered by store-and-forward means, requires informed consent at the originating site, and keeps the patient's right to a later real-time or in-person visit. Definitions come from 8 V.S.A. section 4098a. [5] [6]
Does a compounding pharmacy need a Vermont license to ship to me?
Yes. 26 V.S.A. section 2061 requires every drug outlet to hold a Vermont Board of Pharmacy license in the correct classification. Under the Board's 2026 rules, an outlet outside Vermont doing business in the state must register for the applicable license type (rule 10-9), a pharmacy that compounds must also register as a compounding pharmacy (rule 10-4), and a nonresident compounding pharmacy must submit an inspection report from the prior 2 years (rule 7-4). Check the Office of Professional Regulation license lookup before ordering. [2] [3] [8]
Can a Vermont pharmacy compound peptides that are not on the FDA bulks list?
Generally no. Vermont has no state bulks list, so the federal 503A test applies: the substance must be a component of an approved drug, have a USP or NF monograph, or be on the FDA 503A bulks list. Peptides in FDA Category 2 cannot be compounded. [9] [10]
Sources
Numbered citations above point to these primary sources: the state statute or rule, the pharmacy board, and federal FDA guidance.
- [1]Vermont Board of Pharmacy (Office of Professional Regulation)
- [2]Vermont Board of Pharmacy: statutes, rules, and resources
- [3]Administrative Rules for the Vermont Board of Pharmacy, effective February 1, 2026 (rules 6-2, 7-4, 10-4, 10-9)
- [4]Vermont Office of Professional Regulation
- [5]18 V.S.A. section 9361, Health care providers delivering health care services through telemedicine or by store-and-forward means
- [6]8 V.S.A. section 4098a, Coverage of health care services delivered through telemedicine and by store-and-forward means (definitions)
- [7]26 V.S.A. chapter 36, Pharmacy
- [8]26 V.S.A. section 2061, Registration and licensure of drug outlets
- [9]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
- [10]FDA: Certain bulk drug substances for use in compounding may present significant safety risks (503A and 503B category lists)FDA
Cite this page
Free to cite and quote with a link. Data is licensed CC BY 4.0 with attribution to PeptideAgent.
- APA style
PeptideAgent. (2026, September 22). Are peptides legal in Vermont?. https://peptideagent.ai/legal/vermont- HTML link
<a href="https://peptideagent.ai/legal/vermont">Are peptides legal in Vermont?</a>, PeptideAgent, updated September 22, 2026.